Eevia Health Plc ("Eevia" or "The Company") is welcoming Tuomas Jylhä as interim Chief Financial Officer. Gabriella Beni has decided to leave the Company for personal reasons to focus on private matters. Eevia wishes her the very best in her future endeavors. Tuomas Jylhä will take over the position on July 26th.
Tuomas Jylhä comes from the position of Financial Manager at Rantalainen, a financial administration services firm, with over 1,100 experts in 50 locations in Finland. Tuomas Jylhä has a Master's degree in economics and a professional background in banking and auditing. He is based in the same town where Eevia Health is headquartered - Seinäjoki. Tuomas is part of the team in Rantalainen that provides interim CFO services to clients across Finland.
The company has initiated a search for a permanent CFO and expects to announce a full-time CFO by the end of the year.
"We are very pleased to welcome Tuomas Jylhä as Interim CFO of Eevia. Eevia and Rantalainen have cooperated closely since Eevia was founded in 2017 and Rantalainen has provided competent financial administration, accounting, and payroll services to Eevia since then. As our Interim CFO, Tuomas will strengthen the cooperation on financial administration with Rantalainen. He will streamline the reporting and finance function in the Company going forward, with a focus on controlling and profitability management", comments Stein Ulve, CEO of Eevia Health Plc.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.